Taste Masking and Taste Assessment Services and Technologies Global Market Report 2024

The taste masking and taste assessment services and technologies market size has grown strongly in recent years. It will grow from $80.8 billion in 2023 to $87.44 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historical period can be attributed to several factors, including advancements in pharmaceutical technologies and formulation techniques, evolving consumer preferences for more palatable medications, an increase in the use of nutraceutical products, efforts to enhance patient adherence and compliance through improved taste-masking techniques, and the importance of regulatory compliance in ensuring the safety and efficacy of taste-modified formulations.

The taste masking and taste assessment services and technologies market size is expected to see strong growth in the next few years. It will grow to $118.44 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be linked to various factors, including an increased demand for pediatric medication and treatments tailored for pediatric use, a rise in treatments for chronic diseases, a shift towards consumer-centric approaches in pharmaceuticals, and ongoing innovations in drug delivery methods. Key trends expected in this period encompass the globalization of taste preferences, advancements in sensory evaluation techniques for pharmaceuticals, a growing consumer demand for more palatable supplements and medications, the development of personalized taste-masking solutions, and a focus on natural methods for enhancing flavors in pharmaceutical products.

The expanding interest in combination therapy is poised to drive the growth of the taste masking and taste assessment services and technologies market in the foreseeable future. Combination therapy involves the concurrent or sequential use of two or more treatments or drugs to achieve superior therapeutic outcomes compared to individual treatments. In this context, taste masking and taste assessment services and technologies play a pivotal role, particularly in improving patient compliance and acceptance for combination therapies. By effectively masking the bitter or unpleasant taste of active pharmaceutical ingredients (APIs) or drugs, these services and technologies enhance patient adherence to treatment regimens. Notably, as of May 2022, the Food and Drug Administration (FDA) has approved 35 immunotherapy-based combination therapies, underscoring the escalating interest in combination therapy as a driver for the taste masking and taste assessment services and technologies market.

The increasing level of patient compliance attributed to taste masking is a significant factor contributing to the growth of the taste masking and taste assessment services and technologies market. Patient compliance refers to the extent to which individuals adhere to prescribed treatment plans, medications, or lifestyle changes as directed by their healthcare providers. Taste masking and taste assessment services and technologies play a vital role in ensuring patient acceptability and compliance, particularly overcoming challenges associated with the oral administration of bitter or unpleasant-tasting medications, especially in patient groups such as paediatrics and geriatrics. A report from HPCi Media Limited in 2022 revealed that 90 percent of paediatricians identified a drug's taste and palatability as the most substantial barriers to treatment completion. The utilization of taste masking and taste assessment services and technologies addresses these challenges and is expected to further drive the taste masking market by enhancing patient adherence to prescribed treatments.

Technological advancements stand out as a prominent trend gaining traction in the taste masking and taste assessment services and technologies market. Major companies within this market segment are directing their efforts toward the development of novel methods and technologies aimed at effectively masking the bitter taste of active pharmaceutical ingredients (APIs). An illustrative example is SPI Pharma, a US-based pharmaceutical company, which introduced Actimask in October 2022. Actimask is a cutting-edge taste masking technology that involves producing a thin, micron-sized, uniform hydrogel coating to encapsulate API particles. Leveraging gelatin as a hydrophilic polymer in the aqueous coacervation process, Actimask creates a thin coating over API particles, providing a pleasant mouthfeel without compromising API release or therapeutic effects. This technology not only facilitates easy formulation and processing but also ensures a satisfying patient experience through its slick and smooth hydrogel layer.

Major players in the taste masking and taste assessment services and technologies market are also actively engaged in developing innovative technologies, such as e-tongue testing, to enhance customer offerings. Electronic tongue (e-tongue) testing is a technology designed to replicate human taste perception. A case in point is Medallion Labs, a US-based analytical testing service provider, which introduced e-tongue testing in June 2022 for evaluating flavor characteristics. This emerging technology provides a more objective and comprehensive assessment of a food product's flavor characteristics compared to traditional testing methods. By categorizing selective compounds based on human tongue sensory and biological membrane permeability, e-tongue testing converts molecular information into visual taste data, representing a noteworthy advancement in taste assessment. This innovative approach offers a more precise and thorough evaluation of flavor characteristics and taste perceptions across various food products.

In December 2021, Adare Pharma Solutions, a pharmaceutical contract development and manufacturing organization headquartered in the United States, completed the acquisition of Frontida BioPharm for an undisclosed sum. This acquisition represents a strategic move by Adare to broaden its range of services, incorporating additional capabilities offered by Frontida, notably in the domains of high-potency compound handling and packaging services. Frontida BioPharm, also based in the United States, specializes in providing oral formulations, including expertise in taste masking, controlled release formulations, high-potency formulation manufacturing, and techniques for enhancing bioavailability in pharmaceutical products.

Major companies operating in the taste masking and taste assessment services and technologies market report are Roquette Frères SA, Rochem International Inc., Gattefose SAS, DuPont de Nemours Inc., Dow Pharmaceutical Sciences Inc., SPI Pharma Inc., GPT Pharmaceuticals Pvt. Ltd., Adare Pharmaceuticals Inc., AbbVie Inc., Aavis Pharmaceuticals Corp., Allergen Inc., Asahi Kasei Corporation, Emerald Health Pharmaceutical Corp., ESSA Pharma Inc., Glatt Pharmaceutical Services Corp., Pfizer Inc., Thermo Fisher Scientific Inc., Vertex Pharmaceuticals Inc, FONA International, OptiBiotix Health PLC, Senomyx Inc., Firmenich SA, Givaudan SA, International Flavors & Fragrances Inc., Kerry Group plc, Mane SA, Symrise AG, Takasago International Corporation, Sensient Technologies Corporation, Ashland Global Holdings Inc., BASF SE, Evonik Industries AG, Lonza Group AG, Merck KGaA, Catalent Inc., Fertin Pharma A/S, NextPharma Technologies Holding Limited, Patheon N.V., Quotient Sciences, Senopsys LLC, NextPharma Technologies.

North America was the largest region in the taste masking and taste assessment services and technologies market in 2023. The regions covered in the taste masking and taste assessment services and technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the taste masking and taste assessment services and technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary formulations utilized in taste masking and taste assessment services and technologies include solid formulations and liquid formulations. Solid formulations involve compact tablets formed by compressing medication powder. Various techniques such as coating, microencapsulation, organoleptic methods, hot melt extrusion, inclusion complexation, spray drying, among others, are used to develop these formulations. They find applications in preclinical or clinical operations as well as commercial activities, catering to several end-users including the pharmaceutical and nutraceutical sectors, along with contract manufacturing organizations.

The taste masking and taste assessment services and technologies market research report is one of a series of new reports that provides taste masking and taste assessment services and technologies market statistics, including taste masking and taste assessment services and technologies industry global market size, regional shares, competitors with a taste masking and taste assessment services and technologies market share, detailed taste masking and taste assessment services and technologies market segments, market trends and opportunities, and any further data you may need to thrive in the taste masking and taste assessment services and technologies industry. This taste masking and taste assessment services and technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.